Growth in the use of optical coherence tomography (OCT) for the detection of ocular conditions will drive the U.S. diagnostic ophthalmic market to over $650 million by 2017.

Within this market, the non-mydriatic/mydriatic combination fundus camera segment was one of the fastest-growing. Fundus cameras help to diagnose conditions such as diabetic eye disease, glaucoma and macular degeneration. Growth is due to the technologies’ superior resolution capabilities and ability to image the vascular structure under the retina. Physicians are expected to purchase second and third OCT units for their practices, leading to double-digit growth rates through 2017.

Read more on the Diagnostic Ophthalmic Market in iData Research’s 2011 report: